GSK5764227

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GSK5764227, covering 2025-11-18 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [Phase 3]